Continuous Elastomeric Pump-Based Ropivacaine Wound Instillation after Open Abdominal Aortic Surgery: How Reliable Is the Technique?
Introduction: We aimed at quantifying the impact of continuous wound infusion with ropivacaine 0.33% on morphine administration and subjective pain relief in patients after open abdominal aortic repair in a double-blind, placebo-controlled study.
Methods: Before closing the abdominal wound, 2 multihole ON-Q® Soaker Catheters™ (I-Flow Corporation, Lake Forest, California, USA) were placed pre-peritoneally in opposite directions. Either ropivacaine 0.33% or saline 0.9% was delivered by an elastomeric pump at a rate of 2 mL/h for 72 hours in each of the catheters. Postoperative pain and morphine administration were assessed using the numerical rating scale (NRS) in 4-hour intervals. Total plasma concentrations of ropivacaine, unbound ropivacaine, and ?1-acid glycoprotein (AAG) were measured daily. Mean arterial pressure, pulse rate, oxygen saturation, total amount of morphine administration, ventilation time, and length of stay in the intensive care unit (ICU) were recorded. At the end of the study period, the wound site and the condition of the catheters were assessed.
Results: The study was terminated prematurely due to a malfunction of the elastomeric balloon pump resulting in toxic serum levels of total ropivacaine in 2 patients (11.4 ?mol/L and 10.0 ?mol/L, respectively) on the second postoperative day. Six patients had been allocated to the ropivacaine group, and 9 patients had been allocated to the control group. Demographic and surgical data were similar in both groups. During the first 3 postoperative days, no difference between the ropivacaine and the control group was found in NRS (P = .15, P = .46, and P = .88, respectively) and morphine administration (P = .48). Concentrations of unbound serum ropivacaine (0.11 ± 0.08 ?mol/L) were below toxic level in all patients.
Conclusion: Continuous wound infusion of ropivacaine 0.33% 2 mL/h using an elastomeric system was not reliable and did not improve postoperative pain control in patients after open abdominal aortic surgery.
Baig MK, Zmora O, Derdemezi J, Weiss EG, Nogueras JJ, Wexner SD. 2006. Use of the ON-Q pain management system is associated with decreased postoperative analgesic requirement: double blind randomized placebo pilot study. J Am Coll Surg 202:297-305.nBeaussier M, El'Ayoubi H, Schiffer E, et al. 2007. Continuous preperitoneal infusion of ropivacaine provides effective analgesia and accelerates recovery after colorectal surgery: a randomized, double-blind, placebo-controlled study. Anesthesiology 107:461-8.nBlock BM, Liu SS, Rowlingson AJ, Cowan AR, Cowan JA Jr, Wu CL. 2003. Efficacy of postoperative epidural analgesia: a meta-analysis. JAMA 290:2455-63.nDagtekin O, Hotz A, Kampe S, Auweiler M, Warm M. 2009. Postoperative analgesia and flap perfusion after pedicled TRAM flap reconstruction: continuous wound instillation with ropivacaine 0.2%. A pilot study. J Plast Reconstr Aesthet Surg 62:618-25.nFlores JA, Nishibe T, Koyama M, et al. 2002. Combined spinal and epidural anesthesia for abdominal aortic aneurysm surgery in patients with severe chronic pulmonary obstructive disease. Int Angiol 21:218-21.nForastiere E, Sofra M, Giannarelli D, Fabrizi L, Simone G. 2008. Effectiveness of continuous wound infusion of 0.5% ropivacaine by On-Q pain relief system for postoperative pain management after open nephrectomy. Br J Anaesth 101:841-7.nFredman B, Zohar E, Tarabykin A, et al. 2001. Bupivacaine wound instillation via an electronic patient-controlled analgesia device and a double-catheter system does not decrease postoperative pain or opioid requirements after major abdominal surgery. Anesth Analg 92:189-93.nGómez Rios MA, Vázquez Barreiro L, Nieto Serradilla L, Diz Gómez JC, López Alvarez S. 2009. Efficacy of a continuous infusion of local anesthetic into the surgical wound for pain relief after abdominal hysterectomy [in Spanish]. Rev Esp Anestesiol Reanim 56:417-24.nKehlet H, Holte K. 2001. Effect of postoperative analgesia on surgical outcome. Br J Anaesth 87:62-72.nKehlet H, Wilmore DW. 2002. Multimodal strategies to improve surgical outcome. Am J Surg 183:630-41.nLevack ID, Holmes JD, Robertson GS. 1986. Abdominal wound perfusion for the relief of postoperative pain. Br J Anaesth 58:615-9.nLiu SS, Richman JM, Thirlby RC, Wu CL. 2006. Efficacy of continuous wound catheters delivering local anesthetic for postoperative analgesia: a quantitative and qualitative systematic review of randomized controlled trials. J Am Coll Surg 203:914-32.nMagnano D, Montalbano R, Lamarra M, et al. 2005. Ineffectiveness of local wound anesthesia to reduce postoperative pain after median sternotomy. J Card Surg 20:314-8.nMaurer K, Blumenthal S, Rentsch KM, Schmid ER. 2008. Continuous extrapleural infusion of ropivacaine 0.2% after cardiovascular surgery via the lateral thoracotomy approach. J Cardiothorac Vasc Anesth 22:249-54.nMuehling BM, Orend KH, Sunder-Plassmann L. 2009. Elective infrarenal abdominal aortic aneurysm repair—transperitoneal, retroperitoneal, endovascular? Interact Cardiovasc Thorac Surg 9:802-6.nPfeiffer U, Dodson ME, Van Mourik G, Kirby J, McLoughlin GA. 1991. Wound instillation for postoperative pain relief: a comparison between bupivacaine and saline in patients undergoing aortic surgery. Ann Vasc Surg 5:80-4.nPolglase AL, McMurrick PJ, Simpson PJ, et al. 2007. Continuous wound infusion of local anesthetic for the control of pain after elective abdominal colorectal surgery. Dis Colon Rectum 50:2158-67.nReady LB. 1999. Acute pain: lessons learned from 25,000 patients. Reg Anesth Pain Med 24:499-505.nRichman JM, Liu SS, Courpas G, et al. 2006. Does continuous peripheral nerve block provide superior pain control to opioids? A meta-analysis. Anesth Analg 102:248-57.nSalvemini S. 2008. New intraoperative therapeutic approach to control post-thoracotomy pain in patients who underwent main resection due to lung neoplasm [in Italian]. Minerva Chir 63:335-9.nThiveaud D, Demazieres V, Lafont J. 2005. Comparison of the performance of four elastomeric devices. Eur J Hospt Pharm Pract 11:54-6.nVintar N, Pozlep G, Rawal N, Godec M, Rakovec S. 2002. Incisional self-administration of bupivacaine or ropivacaine provides effective analgesia after inguinal hernia repair. Can J Anaesth 49:481-6.nWheatley GH 3rd, Rosenbaum DH, Paul MC, et al. 2005. Improved pain management outcomes with continuous infusion of a local anesthetic after thoracotomy. J Thorac Cardiovasc Surg 130:464-8.nWhite PF, Rawal S, Latham P, et al. 2003. Use of a continuous local anesthetic infusion for pain management after median sternotomy. Anesthesiology 99:918-23.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).